The rapid development of AmboVent: a simple yet sustainable ventilation solution for use in a pandemic.

COVID-19 (SARS-CoV-2) emerged at the end of 2019, generating a rapidly evolving pandemic, raising serious global health implications. Among them was the fear of a mechanical ventilator shortage due to COVID-19's high contagion rate and pathophysiology. Fears of a ventilator shortage unleashed a wave...

Descripción completa

Detalles Bibliográficos
Publicado en:Minimally Invasive Therapy & Allied Technologies Vol. 31; no. 4; pp. 556 - 567
Autores principales: Meiry, Gideon, Alkaher, David, Mintz, Yoav, Eran, Yuval, Kohn, Aryeh, Kornblau, Giora, Shneorson, Zeev, Alkaher, Shlomo, Sonkin, Roman, Jaffe, Eli
Formato: pictorial research tables/charts Journal Article
Publicado: Taylor & Francis Ltd Apr2022
Acceso en línea:Ver este registro en EBSCOhost
Descripción
Sumario:COVID-19 (SARS-CoV-2) emerged at the end of 2019, generating a rapidly evolving pandemic, raising serious global health implications. Among them was the fear of a mechanical ventilator shortage due to COVID-19's high contagion rate and pathophysiology. Fears of a ventilator shortage unleashed a wave of innovations. This manuscript describes the AmboVent, a ventilator, rapidly developed with a sense of urgency, by a group of Israeli volunteers. Using a decentralized approach, we worked extensively and managed within ten days to create a working ventilator. It utilizes a 64-year-old technological concept, the bag valve mask (BVM), sometimes known by the proprietary name Ambu bag, which we transformed into an automatic, controlled, and feature-rich ventilator by endowing it with contemporary computing technology. Applying a functional rather than a commercial-oriented approach can result in the ad hoc development of lifesaving solutions during a rapidly spreading pandemic.